Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 20030617)

2.

Development of peptides as potential drugs for cancer therapy.

Li ZJ, Cho CH.

Curr Pharm Des. 2010;16(10):1180-9. Review.

PMID:
20166989
3.

Phage peptide display.

Newton J, Deutscher SL.

Handb Exp Pharmacol. 2008;(185 Pt 2):145-63. doi: 10.1007/978-3-540-77496-9_7. Review.

PMID:
18626602
4.

Combinatorial discovery of tumor targeting peptides using phage display.

Landon LA, Deutscher SL.

J Cell Biochem. 2003 Oct 15;90(3):509-17.

PMID:
14523985
5.

Cancer-specific ligands identified from screening of peptide-display libraries.

Mori T.

Curr Pharm Des. 2004;10(19):2335-43. Review.

PMID:
15279612
6.

From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.

Gray BP, Li S, Brown KC.

Bioconjug Chem. 2013 Jan 16;24(1):85-96. doi: 10.1021/bc300498d. Epub 2013 Jan 7.

7.

Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery.

Li ZJ, Cho CH.

J Transl Med. 2012 Sep 19;10 Suppl 1:S1. doi: 10.1186/1479-5876-10-S1-S1. Epub 2012 Sep 19. Review.

8.

A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer.

Chang DK, Lin CT, Wu CH, Wu HC.

PLoS One. 2009;4(1):e4171. doi: 10.1371/journal.pone.0004171. Epub 2009 Jan 12.

9.

Biopanning of phage displayed peptide libraries for the isolation of cell-specific ligands.

McGuire MJ, Li S, Brown KC.

Methods Mol Biol. 2009;504:291-321. doi: 10.1007/978-1-60327-569-9_18. Review.

10.

Landscape phages and their fusion proteins targeted to breast cancer cells.

Fagbohun OA, Bedi D, Grabchenko NI, Deinnocentes PA, Bird RC, Petrenko VA.

Protein Eng Des Sel. 2012 Jun;25(6):271-83. doi: 10.1093/protein/gzs013. Epub 2012 Apr 6.

11.

From combinatorial chemistry to cancer-targeting peptides.

Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, Lam KS.

Mol Pharm. 2007 Sep-Oct;4(5):631-51. Epub 2007 Sep 20. Review.

PMID:
17880166
12.
13.

Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.

Liu J, Liu J, Chu L, Wang Y, Duan Y, Feng L, Yang C, Wang L, Kong D.

Int J Nanomedicine. 2010 Dec 22;6:59-69. doi: 10.2147/IJN.S14601.

14.
15.

Identification of receptor ligands with phage display peptide libraries.

Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R.

J Nucl Med. 1999 May;40(5):883-8. Review.

16.

Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas.

McGuire MJ, Samli KN, Chang YC, Brown KC.

Exp Hematol. 2006 Apr;34(4):443-52.

PMID:
16569591
17.

targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.

Du B, Han H, Wang Z, Kuang L, Wang L, Yu L, Wu M, Zhou Z, Qian M.

Mol Cancer Res. 2010 Feb;8(2):135-44. doi: 10.1158/1541-7786.MCR-09-0339. Epub 2010 Feb 9.

18.

Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries.

Oyama T, Rombel IT, Samli KN, Zhou X, Brown KC.

Biosens Bioelectron. 2006 Apr 15;21(10):1867-75. Epub 2006 Jan 18.

PMID:
16386888
19.

Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents.

Oyama T, Sykes KF, Samli KN, Minna JD, Johnston SA, Brown KC.

Cancer Lett. 2003 Dec 30;202(2):219-30.

PMID:
14643452
20.

Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides.

Whitney M, Crisp JL, Olson ES, Aguilera TA, Gross LA, Ellies LG, Tsien RY.

J Biol Chem. 2010 Jul 16;285(29):22532-41. doi: 10.1074/jbc.M110.138297. Epub 2010 May 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk